Mirtazapine Patent Expiration

Mirtazapine was first introduced by Organon Usa Llc in its drug Remeron on Jun 14, 1996. Another drug containing Mirtazapine is Remeron Soltab. 20 different companies have introduced drugs containing Mirtazapine.


About Veterinary Mirtazapine

Mirtazapine is used in a drug marketed by 1 company: Dechra Ltd.

Other drugs containing Mirtazapine are: Mirataz .

Veterinary Mirtazapine Patents

Given below is the list of patents protecting Mirtazapine, along with the drug name that holds that patent and the company owning that drug.

Filter patents by

Drug Used In Drug Patent Number Drug Patent Expiry Drug Owner
Patent Data
Mirataz US010603672 DECHRA, LTD.

Mirtazapine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Mirtazapine Generic API Manufacturers

Several generic applications have been filed for Mirtazapine. The first generic version for Mirtazapine was by Teva Pharmaceuticals Usa Inc and was approved on Jan 24, 2003. And the latest generic version is by Annora Pharma Private Ltd and was approved on Oct 2, 2025.

Given below is the list of companies who have filed for Mirtazapine generic, along with the locations of their manufacturing plants worldwide.